• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDAP-04-04-L
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/28/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Further information was requested but not received.The results, method, and conclusion codes along with investigation results will be provided in the final report.
 
Event or Problem Description
It was reported that on (b)(6) 2021, a 4/4 amplatzer piccolo occluder was successfully implanted in a (b)(6) old (b)(6) kg patient in the intraductal position.On the morning of (b)(6) 2021, it was found that the device had embolized into the right pulmonary artery (rpa).The patient was brought back into the cath lab where the device was successfully retrieved via transcatheter snare.The physician then attempted to implant a 5/4 amplatzer duct occluder, however it was mis-sized as noted by the retention skirt obstructing aortic flow.The device was removed prior to release and replaced with a 5/4 amplatzer piccolo occluder, which was successfully implanted.There was no clinically significant delay in the procedure and the patient remained hemodynamically stable throughout.The patient is stable.No additional information was provided.
 
Additional Manufacturer Narrative
An event of device embolization was reported.The investigation confirmed the device met visual, functional and dimensional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.The cause of the reported incident could not be conclusively determined.A capa was initiated for further investigation on the device embolization, per internal procedures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PICCOLO OCCLUDER
Common Device Name
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12863582
Report Number2135147-2021-00514
Device Sequence Number1520295
Product Code MAE
UDI-Device Identifier05415067031013
UDI-Public05415067031013
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P020024
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2026
Device Model Number9-PDAP-04-04-L
Device Catalogue Number9-PDAP-04-04-L
Device Lot Number7988055
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/08/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/28/2021
Supplement Date Received by Manufacturer11/24/2021
Initial Report FDA Received Date11/23/2021
Supplement Report FDA Received Date12/22/2021
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/26/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age3 MO
Patient SexMale
Patient Weight4 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-